The acquisition comes two months after the genetic testing company filed for Chapter 11 bankruptcy protection.

Regeneron said it will acquire 23andMe’s genomics service and its bank of 15 million customers’ personal and genetic data as part of the deal. The pharma giant said it plans to use the 23andMe customer data to help drug discovery, and that it will “prioritize the privacy, security, and ethical use of 23andMe’s customer data.”

The proposed sale is expected to close in the third quarter, subject to approval by the U.S. Bankruptcy Court for the Eastern District of Missouri.

We've got all the details about who's eligible for the massive 23andMe data breach settlement and how to make a claim -- plus, who might be able to get as much as $10,000.

Hey New Jerseyands, claims are now open for 23andMe's settlement over a data breach — and payouts may be as high as $10,000. Here's what to know.

A court hearing to consider the transaction’s approval is scheduled for June 17, according to 23andMe Genetics company 23andMe is expected to be purchased by Regeneron Pharmaceuticals, according to announcements shared by both companies Both companies vowed that Regeneron is committed to comply with 23andMe's privacy policies,